Search - tctmd.com

Displaying 241 - 260 of 419

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Patient Selection: Making the Subjective Objective (Frailty, Depression)

Presenter: Marian C. Hawkey

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

Presenter: Anthony N. DeMaria, Karl-Heinz Kuck, Anita Asgar

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Diagnostic Evaluation: Historical Requirements and Emerging Evidence (LHC, TTE, TEE, CTA, Carotid US, PFTs)

Presenter: Kim Guibone

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Complex Retrieval of a Detached MitraClip Using a Two Snare Technique

Presenter: Patrick M. McCarthy, David Meerkin, Benjamin Stripe, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

Presenter: Ted Feldman

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Underdiagnosis of Aortic Stenosis: A Novel Approach Using Machine Learning to Improve Acquisition and Interpretation of Echocardiograms

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pi-Cardia Leaflex Aortic Valve Remodeling: Experimental Findings and Early Human Experiences

Presenter: Tamim Nazif, Steven J. Yakubov, Darren Mylotte

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Eberhard Grube

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Presenter: Randolph P. Martin, Mark J. Russo, Aaron Horne, Jr.

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Applications for the V8 Valvuloplasty Balloon

Presenter: Tamim Nazif, Steven J. Yakubov, Wesley R. Pedersen

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Presenter: Tamim Nazif, Steven J. Yakubov, Susheel K. Kodali

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency

Presenter: Randolph P. Martin, Mark J. Russo, Harindra Wijeysundera

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Advertisement

Patient Selection: Making the Subjective Objective (Frailty, Depression)

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

Diagnostic Evaluation: Historical Requirements and Emerging Evidence (LHC, TTE, TEE, CTA, Carotid US, PFTs)

Complex Retrieval of a Detached MitraClip Using a Two Snare Technique

Cant Beat Safety and Simplicity: Transcatheter Leaflet Approximation Technologies Will Continue to Dominate

The Underdiagnosis of Aortic Stenosis: A Novel Approach Using Machine Learning to Improve Acquisition and Interpretation of Echocardiograms

Pi-Cardia Leaflex Aortic Valve Remodeling: Experimental Findings and Early Human Experiences

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications

Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

New Applications for the V8 Valvuloplasty Balloon

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

UK All-Comers

The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency

Evolut R Low-Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content